

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.66769988 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.64558982 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.45539537 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.28834657 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.10858617 |
| 6 | vocalization behavior (GO:0071625) | 5.06983702 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.83587262 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.72509916 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.59771951 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.57422126 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.56820015 |
| 12 | glutamate secretion (GO:0014047) | 4.55034126 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.41411743 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.39860289 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.24917075 |
| 16 | protein localization to synapse (GO:0035418) | 4.21491550 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.19176451 |
| 18 | exploration behavior (GO:0035640) | 4.17203235 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.09257125 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.08845456 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.08687883 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.05822719 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 3.99340764 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 3.95705053 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 3.92118578 |
| 26 | long-term memory (GO:0007616) | 3.84974397 |
| 27 | transmission of nerve impulse (GO:0019226) | 3.84253260 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 3.82222645 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.80131913 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76924333 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.74799356 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 3.73120651 |
| 33 | cerebellar granule cell differentiation (GO:0021707) | 3.69837230 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 3.68058185 |
| 35 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.64657775 |
| 36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.60289052 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.57896522 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.56495753 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46258052 |
| 40 | neuronal ion channel clustering (GO:0045161) | 3.46097714 |
| 41 | glycine transport (GO:0015816) | 3.42705320 |
| 42 | neurotransmitter transport (GO:0006836) | 3.41776423 |
| 43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.41007102 |
| 44 | neuron recognition (GO:0008038) | 3.34698638 |
| 45 | sodium ion export (GO:0071436) | 3.34074307 |
| 46 | L-amino acid import (GO:0043092) | 3.33428589 |
| 47 | regulation of synaptic plasticity (GO:0048167) | 3.33073814 |
| 48 | activation of protein kinase A activity (GO:0034199) | 3.32794357 |
| 49 | proline transport (GO:0015824) | 3.30575431 |
| 50 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.28887471 |
| 51 | neuromuscular process controlling posture (GO:0050884) | 3.27649804 |
| 52 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.27031618 |
| 53 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26058247 |
| 54 | synaptic vesicle endocytosis (GO:0048488) | 3.24375963 |
| 55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.24336850 |
| 56 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.22168950 |
| 57 | long-term synaptic potentiation (GO:0060291) | 3.22119518 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 3.21035350 |
| 59 | regulation of vesicle fusion (GO:0031338) | 3.18143692 |
| 60 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.17463740 |
| 61 | regulation of neurotransmitter secretion (GO:0046928) | 3.16316450 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 3.14902906 |
| 63 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.12818979 |
| 64 | membrane depolarization during action potential (GO:0086010) | 3.12564068 |
| 65 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.10219861 |
| 66 | presynaptic membrane assembly (GO:0097105) | 3.09773561 |
| 67 | auditory behavior (GO:0031223) | 3.08284339 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.07859448 |
| 69 | prepulse inhibition (GO:0060134) | 3.07795801 |
| 70 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07216605 |
| 71 | axonal fasciculation (GO:0007413) | 3.06037875 |
| 72 | membrane depolarization (GO:0051899) | 3.05819064 |
| 73 | dendrite morphogenesis (GO:0048813) | 3.05744682 |
| 74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.04401806 |
| 75 | regulation of ARF protein signal transduction (GO:0032012) | 3.03008195 |
| 76 | membrane hyperpolarization (GO:0060081) | 3.02228974 |
| 77 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02130128 |
| 78 | presynaptic membrane organization (GO:0097090) | 3.01221246 |
| 79 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00702181 |
| 80 | positive regulation of neurotransmitter transport (GO:0051590) | 2.97921902 |
| 81 | postsynaptic membrane organization (GO:0001941) | 2.96896184 |
| 82 | signal complex assembly (GO:0007172) | 2.95770808 |
| 83 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95762073 |
| 84 | adult walking behavior (GO:0007628) | 2.95625523 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 2.94591000 |
| 86 | potassium ion import (GO:0010107) | 2.93370989 |
| 87 | response to auditory stimulus (GO:0010996) | 2.92048039 |
| 88 | positive regulation of synapse maturation (GO:0090129) | 2.90099788 |
| 89 | cell communication by electrical coupling (GO:0010644) | 2.89789239 |
| 90 | protein targeting to plasma membrane (GO:0072661) | 2.89736470 |
| 91 | learning (GO:0007612) | 2.89280142 |
| 92 | dendritic spine organization (GO:0097061) | 2.86852336 |
| 93 | mating behavior (GO:0007617) | 2.85796799 |
| 94 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.84815050 |
| 95 | central nervous system myelination (GO:0022010) | 2.84645346 |
| 96 | axon ensheathment in central nervous system (GO:0032291) | 2.84645346 |
| 97 | regulation of dendritic spine development (GO:0060998) | 2.84447243 |
| 98 | positive regulation of dendritic spine development (GO:0060999) | 2.84058617 |
| 99 | chemosensory behavior (GO:0007635) | 2.83874201 |
| 100 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.83145293 |
| 101 | positive regulation of Rap GTPase activity (GO:0032854) | 2.82846513 |
| 102 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.81976597 |
| 103 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.81515781 |
| 104 | protein localization to endosome (GO:0036010) | 2.80322650 |
| 105 | amino acid import (GO:0043090) | 2.80185689 |
| 106 | positive regulation of synaptic transmission (GO:0050806) | 2.80182696 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79427631 |
| 108 | regulation of synaptic transmission (GO:0050804) | 2.79030872 |
| 109 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.75883335 |
| 110 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74351312 |
| 111 | negative regulation of cell killing (GO:0031342) | 2.74351312 |
| 112 | cellular response to monoamine stimulus (GO:0071868) | 2.74304067 |
| 113 | cellular response to catecholamine stimulus (GO:0071870) | 2.74304067 |
| 114 | positive regulation of receptor recycling (GO:0001921) | 2.64257956 |
| 115 | regulation of ARF GTPase activity (GO:0032312) | 2.57854830 |
| 116 | positive regulation of protein dephosphorylation (GO:0035307) | 2.54731144 |
| 117 | cellular response to epinephrine stimulus (GO:0071872) | 2.52719549 |
| 118 | positive regulation of fibroblast migration (GO:0010763) | 2.49258714 |
| 119 | barbed-end actin filament capping (GO:0051016) | 2.47244539 |
| 120 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.45831878 |
| 121 | regulation of early endosome to late endosome transport (GO:2000641) | 2.43127309 |
| 122 | regulation of synapse maturation (GO:0090128) | 2.42772957 |
| 123 | regulation of Rap GTPase activity (GO:0032317) | 2.42598342 |
| 124 | creatine metabolic process (GO:0006600) | 2.32191948 |
| 125 | actin filament capping (GO:0051693) | 2.31572056 |
| 126 | cell-substrate adherens junction assembly (GO:0007045) | 2.31117213 |
| 127 | focal adhesion assembly (GO:0048041) | 2.31117213 |
| 128 | stress fiber assembly (GO:0043149) | 2.30834332 |
| 129 | dopamine receptor signaling pathway (GO:0007212) | 2.30826029 |
| 130 | adherens junction assembly (GO:0034333) | 2.29860961 |
| 131 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.27470686 |
| 132 | response to parathyroid hormone (GO:0071107) | 2.27147507 |
| 133 | potassium ion homeostasis (GO:0055075) | 2.22721726 |
| 134 | cellular sodium ion homeostasis (GO:0006883) | 2.22089264 |
| 135 | response to catecholamine (GO:0071869) | 2.20066162 |
| 136 | response to monoamine (GO:0071867) | 2.20066162 |
| 137 | mannose metabolic process (GO:0006013) | 2.19512885 |
| 138 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.17211102 |
| 139 | regulation of regulated secretory pathway (GO:1903305) | 2.16562682 |
| 140 | cell communication involved in cardiac conduction (GO:0086065) | 2.14823387 |
| 141 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.13687291 |
| 142 | gas transport (GO:0015669) | 2.13494974 |
| 143 | oxygen transport (GO:0015671) | 2.13420327 |
| 144 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.12976547 |
| 145 | actin filament polymerization (GO:0030041) | 2.10400184 |
| 146 | cell migration in hindbrain (GO:0021535) | 2.09429124 |
| 147 | adenosine receptor signaling pathway (GO:0001973) | 2.08157894 |
| 148 | regulation of protein dephosphorylation (GO:0035304) | 2.06890838 |
| 149 | NADH metabolic process (GO:0006734) | 2.05877564 |
| 150 | cardiac muscle contraction (GO:0060048) | 2.05810158 |
| 151 | regulation of extracellular matrix disassembly (GO:0010715) | 2.04431560 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.03754979 |
| 153 | negative regulation of myotube differentiation (GO:0010832) | 2.03499816 |
| 154 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.01270063 |
| 155 | regulation of platelet aggregation (GO:0090330) | 1.98393953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.74499920 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.22609097 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93131547 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90800811 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86670897 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69262895 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64303884 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64303884 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.63863195 |
| 10 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.59055730 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.58193226 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.55939818 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49263078 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48228328 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47859386 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44155915 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.34349222 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33814885 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.32776353 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.25254957 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23643180 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.16503903 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15523835 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.13367530 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11127407 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10964167 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10536179 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.08638193 |
| 29 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00969008 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00651258 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00269633 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87823825 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87774510 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.86034468 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85171394 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83769013 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79647894 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79041916 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77895457 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.72939396 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65071528 |
| 42 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.58988702 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55915684 |
| 44 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.52254642 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50809087 |
| 46 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.50312369 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49254023 |
| 48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45935572 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44680567 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42527969 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42238523 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42112375 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41903989 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40074060 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38131201 |
| 56 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.37782642 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35989779 |
| 58 | * P68_20966046_ChIP-Seq_HELA_Human | 1.35880790 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33979510 |
| 60 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33597534 |
| 61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.33353652 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31761087 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31620027 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31023248 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29954745 |
| 66 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29818239 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.29122054 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27960671 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27465883 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26906516 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25983859 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25498525 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24932653 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24124192 |
| 75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23460182 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22818835 |
| 77 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22655010 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21878945 |
| 79 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21243409 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21206738 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19998426 |
| 82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19989272 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19946633 |
| 84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19425371 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19250143 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18849207 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18195538 |
| 88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18175942 |
| 89 | AR_19668381_ChIP-Seq_PC3_Human | 1.17126112 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16915631 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16728433 |
| 92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16251837 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14449520 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14021949 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13843741 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13496121 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13016093 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12578935 |
| 99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11991020 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11666563 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11088627 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09572203 |
| 103 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09312253 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08848141 |
| 105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08682445 |
| 106 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08379002 |
| 107 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.08204138 |
| 108 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07632732 |
| 109 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07568657 |
| 110 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07507010 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07433660 |
| 112 | MAF_26560356_Chip-Seq_TH1_Human | 1.07262425 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07009404 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06917980 |
| 115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06915694 |
| 116 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06518587 |
| 117 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06401090 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06290058 |
| 119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06290058 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06161167 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05798043 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05281259 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04835752 |
| 124 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04827674 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04051244 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03438518 |
| 127 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01584455 |
| 128 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.00133072 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98237382 |
| 130 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96911469 |
| 131 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96633786 |
| 132 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95816203 |
| 133 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95607877 |
| 134 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95537279 |
| 135 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94965182 |
| 136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94688640 |
| 137 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94520575 |
| 138 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94484479 |
| 139 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93870984 |
| 140 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.93795402 |
| 141 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93563471 |
| 142 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93545307 |
| 143 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93297982 |
| 144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93282642 |
| 145 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93268851 |
| 146 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92903228 |
| 147 | MAF_26560356_Chip-Seq_TH2_Human | 0.92722194 |
| 148 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92586778 |
| 149 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.91661544 |
| 150 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90814340 |
| 151 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90620546 |
| 152 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90526352 |
| 153 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90238420 |
| 154 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89364723 |
| 155 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89070663 |
| 156 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88110943 |
| 157 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88110943 |
| 158 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87113248 |
| 159 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85489593 |
| 160 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84049672 |
| 161 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82654262 |
| 162 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82061408 |
| 163 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81206529 |
| 164 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81101345 |
| 165 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79748847 |
| 166 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79668399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.38959941 |
| 2 | MP0003880_abnormal_central_pattern | 4.62611411 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.09222217 |
| 4 | MP0004270_analgesia | 3.57620716 |
| 5 | MP0009745_abnormal_behavioral_response | 3.44984325 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.19054793 |
| 7 | MP0002064_seizures | 3.18355500 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.04933258 |
| 9 | MP0009046_muscle_twitch | 2.96741211 |
| 10 | MP0002822_catalepsy | 2.95659195 |
| 11 | MP0002272_abnormal_nervous_system | 2.78936237 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.76879252 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.73715068 |
| 14 | MP0001486_abnormal_startle_reflex | 2.70294506 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.64011120 |
| 16 | MP0008260_abnormal_autophagy | 2.61813286 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.46864149 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.33205066 |
| 19 | MP0008569_lethality_at_weaning | 2.11805782 |
| 20 | MP0005451_abnormal_body_composition | 2.08916366 |
| 21 | MP0003303_peritoneal_inflammation | 2.07960553 |
| 22 | MP0004130_abnormal_muscle_cell | 2.07943636 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.07114705 |
| 24 | MP0004885_abnormal_endolymph | 2.02812456 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.98943272 |
| 26 | MP0003329_amyloid_beta_deposits | 1.97698099 |
| 27 | MP0002735_abnormal_chemical_nociception | 1.94018697 |
| 28 | MP0002736_abnormal_nociception_after | 1.93452739 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.89911870 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.87894070 |
| 31 | MP0001970_abnormal_pain_threshold | 1.82830026 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.80433471 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.78905884 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.73144165 |
| 35 | MP0004924_abnormal_behavior | 1.70508715 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.70508715 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.70055199 |
| 38 | MP0000778_abnormal_nervous_system | 1.70019695 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.64473612 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.64153071 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.62971968 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.61538181 |
| 43 | MP0003436_decreased_susceptibility_to | 1.60201075 |
| 44 | MP0002184_abnormal_innervation | 1.59835675 |
| 45 | MP0003787_abnormal_imprinting | 1.57144690 |
| 46 | MP0000920_abnormal_myelination | 1.56808851 |
| 47 | MP0001958_emphysema | 1.56806413 |
| 48 | MP0000955_abnormal_spinal_cord | 1.56629008 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.55479158 |
| 50 | MP0004858_abnormal_nervous_system | 1.48942305 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.47602123 |
| 52 | MP0003633_abnormal_nervous_system | 1.47149431 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.45952764 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.44359863 |
| 55 | MP0001905_abnormal_dopamine_level | 1.38115827 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.37891360 |
| 57 | MP0003879_abnormal_hair_cell | 1.37268072 |
| 58 | MP0004142_abnormal_muscle_tone | 1.36512232 |
| 59 | MP0001529_abnormal_vocalization | 1.35274485 |
| 60 | MP0001984_abnormal_olfaction | 1.33309352 |
| 61 | MP0003690_abnormal_glial_cell | 1.31699593 |
| 62 | MP0009840_abnormal_foam_cell | 1.28420826 |
| 63 | MP0003631_nervous_system_phenotype | 1.28222198 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.26853599 |
| 65 | MP0003724_increased_susceptibility_to | 1.25662985 |
| 66 | MP0002229_neurodegeneration | 1.24095724 |
| 67 | MP0004742_abnormal_vestibular_system | 1.23996167 |
| 68 | MP0003566_abnormal_cell_adhesion | 1.23658077 |
| 69 | MP0000751_myopathy | 1.21015809 |
| 70 | MP0003045_fibrosis | 1.20159991 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.17193516 |
| 72 | MP0003122_maternal_imprinting | 1.15942672 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.11958909 |
| 74 | MP0003091_abnormal_cell_migration | 1.11949492 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 1.11821342 |
| 76 | MP0001849_ear_inflammation | 1.11444297 |
| 77 | MP0005166_decreased_susceptibility_to | 1.10373125 |
| 78 | MP0002152_abnormal_brain_morphology | 1.09756094 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.09676653 |
| 80 | MP0003279_aneurysm | 1.07467056 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.04452365 |
| 82 | MP0005409_darkened_coat_color | 1.03174852 |
| 83 | MP0003634_abnormal_glial_cell | 1.03029096 |
| 84 | MP0004043_abnormal_pH_regulation | 1.02059605 |
| 85 | MP0003632_abnormal_nervous_system | 1.00966986 |
| 86 | MP0000759_abnormal_skeletal_muscle | 1.00355577 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 1.00021306 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.99824558 |
| 89 | MP0000749_muscle_degeneration | 0.99769821 |
| 90 | MP0001177_atelectasis | 0.98821382 |
| 91 | MP0004087_abnormal_muscle_fiber | 0.98443828 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.98263799 |
| 93 | MP0004947_skin_inflammation | 0.98120344 |
| 94 | MP0003866_abnormal_defecation | 0.97786491 |
| 95 | MP0002069_abnormal_eating/drinking_beha | 0.97507138 |
| 96 | MP0004036_abnormal_muscle_relaxation | 0.95831430 |
| 97 | MP0008874_decreased_physiological_sensi | 0.95282569 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.93819205 |
| 99 | MP0006138_congestive_heart_failure | 0.93539963 |
| 100 | MP0008872_abnormal_physiological_respon | 0.93507142 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.92521312 |
| 102 | MP0005535_abnormal_body_temperature | 0.92515653 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 0.91861628 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.91695626 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.90380913 |
| 106 | MP0004085_abnormal_heartbeat | 0.90307033 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.90269795 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.89413050 |
| 109 | MP0002249_abnormal_larynx_morphology | 0.89331478 |
| 110 | MP0002971_abnormal_brown_adipose | 0.89031107 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.85872690 |
| 112 | MP0001188_hyperpigmentation | 0.85312443 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.85051517 |
| 114 | MP0003283_abnormal_digestive_organ | 0.82767937 |
| 115 | MP0003075_altered_response_to | 0.82326569 |
| 116 | MP0000681_abnormal_thyroid_gland | 0.82098822 |
| 117 | MP0009278_abnormal_bone_marrow | 0.81428619 |
| 118 | MP0005623_abnormal_meninges_morphology | 0.80865275 |
| 119 | MP0005083_abnormal_biliary_tract | 0.80582268 |
| 120 | MP0000604_amyloidosis | 0.80341631 |
| 121 | MP0000631_abnormal_neuroendocrine_gland | 0.79356789 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.79090621 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.78392037 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.78378457 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.75953312 |
| 126 | MP0002090_abnormal_vision | 0.74681971 |
| 127 | MP0005670_abnormal_white_adipose | 0.73860173 |
| 128 | MP0003828_pulmonary_edema | 0.73512172 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.72652285 |
| 130 | MP0000678_abnormal_parathyroid_gland | 0.72370767 |
| 131 | MP0005388_respiratory_system_phenotype | 0.71562106 |
| 132 | MP0002133_abnormal_respiratory_system | 0.71562106 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.70779569 |
| 134 | MP0002106_abnormal_muscle_physiology | 0.70472863 |
| 135 | MP0001851_eye_inflammation | 0.70102523 |
| 136 | MP0010630_abnormal_cardiac_muscle | 0.69912439 |
| 137 | MP0002089_abnormal_postnatal_growth/wei | 0.69614584 |
| 138 | MP0005025_abnormal_response_to | 0.68498443 |
| 139 | MP0002332_abnormal_exercise_endurance | 0.68038780 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.67472020 |
| 141 | MP0000747_muscle_weakness | 0.66182409 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.65194304 |
| 143 | MP0006072_abnormal_retinal_apoptosis | 0.64399059 |
| 144 | MP0002638_abnormal_pupillary_reflex | 0.64171450 |
| 145 | MP0005410_abnormal_fertilization | 0.64065417 |
| 146 | MP0005499_abnormal_olfactory_system | 0.62387825 |
| 147 | MP0005394_taste/olfaction_phenotype | 0.62387825 |
| 148 | MP0004510_myositis | 0.62037411 |
| 149 | MP0001299_abnormal_eye_distance/ | 0.61896112 |
| 150 | MP0000569_abnormal_digit_pigmentation | 0.59221734 |
| 151 | MP0004215_abnormal_myocardial_fiber | 0.58789163 |
| 152 | MP0001664_abnormal_digestion | 0.58696023 |
| 153 | MP0004484_altered_response_of | 0.57571122 |
| 154 | MP0001943_abnormal_respiration | 0.54505312 |
| 155 | MP0010769_abnormal_survival | 0.53343520 |
| 156 | MP0000003_abnormal_adipose_tissue | 0.52925606 |
| 157 | MP0010770_preweaning_lethality | 0.50173235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.81216027 |
| 2 | Myokymia (HP:0002411) | 6.57452937 |
| 3 | Focal seizures (HP:0007359) | 5.40033541 |
| 4 | Visual hallucinations (HP:0002367) | 4.84524510 |
| 5 | Atonic seizures (HP:0010819) | 4.35850716 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.19251749 |
| 7 | Febrile seizures (HP:0002373) | 4.15526239 |
| 8 | Obstructive sleep apnea (HP:0002870) | 4.13477353 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.09594514 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.08530288 |
| 11 | Ankle clonus (HP:0011448) | 3.86188980 |
| 12 | Action tremor (HP:0002345) | 3.85424752 |
| 13 | Absence seizures (HP:0002121) | 3.66917072 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.55439950 |
| 15 | Broad-based gait (HP:0002136) | 3.52621307 |
| 16 | Abnormality of the corticospinal tract (HP:0002492) | 3.47563820 |
| 17 | Dysmetria (HP:0001310) | 3.47035843 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.43931325 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.41979724 |
| 20 | Dialeptic seizures (HP:0011146) | 3.40918376 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.36946780 |
| 22 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.36946780 |
| 23 | Dysdiadochokinesis (HP:0002075) | 3.30777542 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.24207132 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.21788821 |
| 26 | Postural instability (HP:0002172) | 3.20225294 |
| 27 | Depression (HP:0000716) | 3.18219007 |
| 28 | Spastic gait (HP:0002064) | 3.14262656 |
| 29 | Cerebral inclusion bodies (HP:0100314) | 3.09120275 |
| 30 | Poor eye contact (HP:0000817) | 3.06401888 |
| 31 | Intention tremor (HP:0002080) | 3.06319062 |
| 32 | Anxiety (HP:0000739) | 2.98142138 |
| 33 | Abnormal social behavior (HP:0012433) | 2.91590025 |
| 34 | Impaired social interactions (HP:0000735) | 2.91590025 |
| 35 | Truncal ataxia (HP:0002078) | 2.90374894 |
| 36 | Hyperventilation (HP:0002883) | 2.89027047 |
| 37 | Urinary urgency (HP:0000012) | 2.88930346 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 2.81277483 |
| 39 | Exercise-induced myalgia (HP:0003738) | 2.78338333 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.77941947 |
| 41 | Increased connective tissue (HP:0009025) | 2.74327682 |
| 42 | Hyporeflexia of lower limbs (HP:0002600) | 2.72434631 |
| 43 | Scanning speech (HP:0002168) | 2.70372672 |
| 44 | Difficulty running (HP:0009046) | 2.68194920 |
| 45 | Distal lower limb muscle weakness (HP:0009053) | 2.66314601 |
| 46 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.65474420 |
| 47 | Hemiparesis (HP:0001269) | 2.63725027 |
| 48 | Genetic anticipation (HP:0003743) | 2.63656405 |
| 49 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60958411 |
| 50 | Muscle fiber splitting (HP:0003555) | 2.59493915 |
| 51 | Hemiplegia (HP:0002301) | 2.58500180 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.58174466 |
| 53 | Lower limb muscle weakness (HP:0007340) | 2.57121831 |
| 54 | Type 1 muscle fiber predominance (HP:0003803) | 2.55791599 |
| 55 | Amblyopia (HP:0000646) | 2.55723943 |
| 56 | Drooling (HP:0002307) | 2.54071504 |
| 57 | Excessive salivation (HP:0003781) | 2.54071504 |
| 58 | Torticollis (HP:0000473) | 2.53615055 |
| 59 | Papilledema (HP:0001085) | 2.52564141 |
| 60 | Cerebral aneurysm (HP:0004944) | 2.51843557 |
| 61 | Abnormality of the lower motor neuron (HP:0002366) | 2.48769685 |
| 62 | Myopathic facies (HP:0002058) | 2.47859580 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.47352763 |
| 64 | Diplopia (HP:0000651) | 2.46806575 |
| 65 | Abnormality of binocular vision (HP:0011514) | 2.46806575 |
| 66 | Impaired smooth pursuit (HP:0007772) | 2.36434303 |
| 67 | Bradykinesia (HP:0002067) | 2.35807596 |
| 68 | Impaired vibratory sensation (HP:0002495) | 2.32796290 |
| 69 | Insomnia (HP:0100785) | 2.31863952 |
| 70 | Mutism (HP:0002300) | 2.31597524 |
| 71 | Progressive inability to walk (HP:0002505) | 2.31279214 |
| 72 | Focal dystonia (HP:0004373) | 2.31084471 |
| 73 | Termporal pattern (HP:0011008) | 2.30851802 |
| 74 | Insidious onset (HP:0003587) | 2.30851802 |
| 75 | Foot dorsiflexor weakness (HP:0009027) | 2.30204234 |
| 76 | Upper limb amyotrophy (HP:0009129) | 2.26385887 |
| 77 | Distal upper limb amyotrophy (HP:0007149) | 2.26385887 |
| 78 | Absent speech (HP:0001344) | 2.23858526 |
| 79 | Annular pancreas (HP:0001734) | 2.23543807 |
| 80 | Ventricular fibrillation (HP:0001663) | 2.21626826 |
| 81 | Stereotypic behavior (HP:0000733) | 2.21370568 |
| 82 | Increased circulating renin level (HP:0000848) | 2.18875796 |
| 83 | Slow saccadic eye movements (HP:0000514) | 2.16771771 |
| 84 | Hypercortisolism (HP:0001578) | 2.15920691 |
| 85 | Clonus (HP:0002169) | 2.15637623 |
| 86 | Epileptiform EEG discharges (HP:0011182) | 2.14704156 |
| 87 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.11102098 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09271356 |
| 89 | Abnormality of the foot musculature (HP:0001436) | 2.08432873 |
| 90 | Craniofacial dystonia (HP:0012179) | 2.07059646 |
| 91 | Abnormality of saccadic eye movements (HP:0000570) | 2.05466186 |
| 92 | Megalencephaly (HP:0001355) | 2.03731624 |
| 93 | Dysmetric saccades (HP:0000641) | 2.03438178 |
| 94 | Status epilepticus (HP:0002133) | 2.02914022 |
| 95 | Bundle branch block (HP:0011710) | 2.01668722 |
| 96 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00700599 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 2.00615755 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 2.00526971 |
| 99 | Hypsarrhythmia (HP:0002521) | 1.99548240 |
| 100 | Protrusio acetabuli (HP:0003179) | 1.98960895 |
| 101 | Abnormal EKG (HP:0003115) | 1.98085169 |
| 102 | Lower limb amyotrophy (HP:0007210) | 1.97598017 |
| 103 | Psychosis (HP:0000709) | 1.96759299 |
| 104 | Pheochromocytoma (HP:0002666) | 1.96538362 |
| 105 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95665086 |
| 106 | Prolonged QT interval (HP:0001657) | 1.95488775 |
| 107 | Peripheral hypomyelination (HP:0007182) | 1.95380210 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 1.92981757 |
| 109 | Tetraplegia (HP:0002445) | 1.92967233 |
| 110 | Agitation (HP:0000713) | 1.90925552 |
| 111 | Anosmia (HP:0000458) | 1.88019536 |
| 112 | Blue irides (HP:0000635) | 1.87911425 |
| 113 | EMG: neuropathic changes (HP:0003445) | 1.87263054 |
| 114 | Bowel incontinence (HP:0002607) | 1.87070325 |
| 115 | Polyphagia (HP:0002591) | 1.86775075 |
| 116 | Sudden death (HP:0001699) | 1.86735340 |
| 117 | Onion bulb formation (HP:0003383) | 1.86541868 |
| 118 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85996242 |
| 119 | Muscle fiber inclusion bodies (HP:0100299) | 1.85749147 |
| 120 | Gait ataxia (HP:0002066) | 1.85263657 |
| 121 | Cellulitis (HP:0100658) | 1.84753191 |
| 122 | Difficulty climbing stairs (HP:0003551) | 1.83233051 |
| 123 | Metabolic alkalosis (HP:0200114) | 1.82838565 |
| 124 | Hyperacusis (HP:0010780) | 1.82770506 |
| 125 | Rigidity (HP:0002063) | 1.82503900 |
| 126 | EMG: myopathic abnormalities (HP:0003458) | 1.82445236 |
| 127 | Rapidly progressive (HP:0003678) | 1.82215168 |
| 128 | Aplasia involving bones of the extremities (HP:0009825) | 1.82172667 |
| 129 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.82172667 |
| 130 | Aplasia of the phalanges of the hand (HP:0009802) | 1.82172667 |
| 131 | Decreased motor nerve conduction velocity (HP:0003431) | 1.80534189 |
| 132 | Fetal akinesia sequence (HP:0001989) | 1.80521370 |
| 133 | Abnormality of salivation (HP:0100755) | 1.79946160 |
| 134 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.79887154 |
| 135 | Resting tremor (HP:0002322) | 1.79732817 |
| 136 | Growth hormone excess (HP:0000845) | 1.79528118 |
| 137 | Sleep apnea (HP:0010535) | 1.79494763 |
| 138 | Hand muscle atrophy (HP:0009130) | 1.79271630 |
| 139 | Stridor (HP:0010307) | 1.78996273 |
| 140 | Hyperparathyroidism (HP:0000843) | 1.78924957 |
| 141 | Aneurysm (HP:0002617) | 1.78600687 |
| 142 | Broad face (HP:0000283) | 1.77134576 |
| 143 | Nemaline bodies (HP:0003798) | 1.74630695 |
| 144 | Akinesia (HP:0002304) | 1.71543105 |
| 145 | Cholecystitis (HP:0001082) | 1.70063422 |
| 146 | Abnormal gallbladder physiology (HP:0012438) | 1.70063422 |
| 147 | Spinal canal stenosis (HP:0003416) | 1.69384321 |
| 148 | Amyloidosis (HP:0011034) | 1.68458576 |
| 149 | Polycythemia (HP:0001901) | 1.68297192 |
| 150 | Achilles tendon contracture (HP:0001771) | 1.68133791 |
| 151 | Abnormal atrioventricular conduction (HP:0005150) | 1.67741071 |
| 152 | Flat acetabular roof (HP:0003180) | 1.67301969 |
| 153 | Dysostosis multiplex (HP:0000943) | 1.67162997 |
| 154 | Vertebral compression fractures (HP:0002953) | 1.66312262 |
| 155 | Shallow orbits (HP:0000586) | 1.65808930 |
| 156 | Round ear (HP:0100830) | 1.64937639 |
| 157 | Hypochromic microcytic anemia (HP:0004840) | 1.64355769 |
| 158 | Gingivitis (HP:0000230) | 1.63631276 |
| 159 | Apathy (HP:0000741) | 1.63350608 |
| 160 | Spontaneous hematomas (HP:0007420) | 1.63070236 |
| 161 | Ventricular arrhythmia (HP:0004308) | 1.62178372 |
| 162 | Vascular tortuosity (HP:0004948) | 1.61147172 |
| 163 | Prolonged bleeding time (HP:0003010) | 1.60528951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.21816020 |
| 2 | NTRK3 | 4.17474749 |
| 3 | TRIB3 | 3.23664962 |
| 4 | MAP3K9 | 3.17014456 |
| 5 | MAP3K4 | 2.51779432 |
| 6 | DAPK2 | 2.48158409 |
| 7 | ERN1 | 2.47995321 |
| 8 | PRKD3 | 2.47326599 |
| 9 | MARK1 | 2.41929704 |
| 10 | MINK1 | 2.23047783 |
| 11 | NTRK2 | 2.22401387 |
| 12 | PAK6 | 2.11616181 |
| 13 | MAP2K7 | 2.10752170 |
| 14 | TNIK | 2.08719757 |
| 15 | SIK1 | 1.83199784 |
| 16 | NTRK1 | 1.80236298 |
| 17 | MAP2K3 | 1.70556536 |
| 18 | MAP3K11 | 1.68657671 |
| 19 | KSR2 | 1.65805854 |
| 20 | PNCK | 1.62198884 |
| 21 | TTN | 1.59930924 |
| 22 | CAMKK1 | 1.58747301 |
| 23 | CDK5 | 1.56915681 |
| 24 | PRPF4B | 1.56232881 |
| 25 | EPHB1 | 1.55710241 |
| 26 | CDK19 | 1.55562885 |
| 27 | MAP2K4 | 1.54917599 |
| 28 | SIK2 | 1.53931645 |
| 29 | MAP3K13 | 1.48741803 |
| 30 | UHMK1 | 1.48451688 |
| 31 | RIPK4 | 1.46669203 |
| 32 | OXSR1 | 1.42576519 |
| 33 | STK38 | 1.41380970 |
| 34 | MAPK13 | 1.40602159 |
| 35 | SGK223 | 1.40020992 |
| 36 | SGK494 | 1.40020992 |
| 37 | SMG1 | 1.34702637 |
| 38 | CASK | 1.33701472 |
| 39 | PRKCH | 1.33106146 |
| 40 | FES | 1.30022774 |
| 41 | TYRO3 | 1.27241842 |
| 42 | TAOK2 | 1.20492314 |
| 43 | EEF2K | 1.20394863 |
| 44 | STK39 | 1.19549086 |
| 45 | PHKG1 | 1.18662178 |
| 46 | PHKG2 | 1.18662178 |
| 47 | PINK1 | 1.14056787 |
| 48 | MAP3K12 | 1.13177478 |
| 49 | FGFR4 | 1.11517643 |
| 50 | MAP3K3 | 1.10162000 |
| 51 | PRKCG | 1.09980417 |
| 52 | TNK2 | 1.08250602 |
| 53 | GRK5 | 1.07846871 |
| 54 | MAP3K2 | 1.07703532 |
| 55 | GRK6 | 1.06953103 |
| 56 | MARK2 | 1.06605206 |
| 57 | CAMK1 | 1.06149168 |
| 58 | WNK1 | 1.02480523 |
| 59 | KSR1 | 1.02150838 |
| 60 | TESK1 | 1.01728832 |
| 61 | SGK2 | 1.01600977 |
| 62 | DAPK1 | 1.01434661 |
| 63 | STK11 | 0.99491319 |
| 64 | NEK6 | 0.99488370 |
| 65 | CAMK2A | 0.98762312 |
| 66 | SGK3 | 0.95763900 |
| 67 | CAMK1G | 0.93224873 |
| 68 | MAP3K7 | 0.93130578 |
| 69 | PLK2 | 0.92841032 |
| 70 | CAMK2B | 0.92131611 |
| 71 | PKN2 | 0.89149490 |
| 72 | MAP4K1 | 0.88512232 |
| 73 | BMPR2 | 0.88389525 |
| 74 | PKN1 | 0.87948715 |
| 75 | ZAP70 | 0.83609309 |
| 76 | DYRK1B | 0.83119948 |
| 77 | ARAF | 0.81922923 |
| 78 | RPS6KA2 | 0.80907045 |
| 79 | HIPK2 | 0.80889731 |
| 80 | PTK2B | 0.80790740 |
| 81 | CDK15 | 0.80642195 |
| 82 | PAK3 | 0.79163463 |
| 83 | SGK1 | 0.78963388 |
| 84 | TAOK1 | 0.78882226 |
| 85 | CDK18 | 0.78526098 |
| 86 | DYRK1A | 0.76802276 |
| 87 | PTK6 | 0.76249166 |
| 88 | CDK12 | 0.74398953 |
| 89 | PDK1 | 0.74065360 |
| 90 | LMTK2 | 0.73594752 |
| 91 | ALK | 0.73279552 |
| 92 | PDPK1 | 0.72828600 |
| 93 | CDK14 | 0.72636303 |
| 94 | CDC42BPA | 0.72336630 |
| 95 | SIK3 | 0.70954532 |
| 96 | CDK11A | 0.70510384 |
| 97 | LATS2 | 0.70206388 |
| 98 | PDGFRA | 0.67683140 |
| 99 | WNK4 | 0.67230521 |
| 100 | PRKG2 | 0.67174935 |
| 101 | JAK1 | 0.66066278 |
| 102 | JAK2 | 0.65770640 |
| 103 | BLK | 0.65501081 |
| 104 | MAP3K6 | 0.65466648 |
| 105 | TYK2 | 0.65247371 |
| 106 | IRAK2 | 0.64468032 |
| 107 | CAMK2D | 0.63615109 |
| 108 | MAP3K1 | 0.63609651 |
| 109 | RET | 0.63387931 |
| 110 | ICK | 0.62534091 |
| 111 | BMX | 0.62080223 |
| 112 | CSK | 0.61409501 |
| 113 | MAPKAPK5 | 0.61068202 |
| 114 | PRKD2 | 0.60528526 |
| 115 | FGR | 0.59954079 |
| 116 | FGFR2 | 0.59779193 |
| 117 | CSNK1G2 | 0.58951893 |
| 118 | FYN | 0.57946345 |
| 119 | MAPK7 | 0.57801690 |
| 120 | FGFR3 | 0.56842651 |
| 121 | CAMK4 | 0.56750409 |
| 122 | PRKCE | 0.56705301 |
| 123 | ROCK2 | 0.56027783 |
| 124 | IRAK4 | 0.55447709 |
| 125 | HCK | 0.54946896 |
| 126 | RPS6KA3 | 0.54002681 |
| 127 | CAMKK2 | 0.53852109 |
| 128 | RIPK1 | 0.53383420 |
| 129 | DMPK | 0.53334308 |
| 130 | CAMK2G | 0.52793524 |
| 131 | TBK1 | 0.51506640 |
| 132 | PRKCZ | 0.50578262 |
| 133 | OBSCN | 0.49730914 |
| 134 | MAP2K6 | 0.49535209 |
| 135 | MAPK10 | 0.48945788 |
| 136 | PTK2 | 0.46893290 |
| 137 | MTOR | 0.46314924 |
| 138 | INSRR | 0.46087692 |
| 139 | MAP2K2 | 0.45435309 |
| 140 | MAPK12 | 0.40477340 |
| 141 | PRKCQ | 0.37785742 |
| 142 | PRKCB | 0.37343857 |
| 143 | PRKD1 | 0.37077465 |
| 144 | RAF1 | 0.36713101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.46645171 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.86615209 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79777631 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71065688 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66107374 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61458100 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.57070812 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.55589824 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.51583953 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.39811955 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.17483343 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05804358 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05395859 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.03124103 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.98637571 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.91747641 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88721897 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.79723191 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69333370 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66705628 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.65865873 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60574676 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59730957 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.58709713 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58382959 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51442972 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35975547 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35856482 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34812097 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33668800 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31633857 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27365014 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26966757 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25395345 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18560513 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.17741976 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15248914 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14649596 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.11216975 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09644589 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07653214 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07196017 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06711010 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02903361 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02770464 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.01662802 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01397725 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00603315 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96715329 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96402343 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.95897380 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95722898 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.95608898 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92815081 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92477871 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92167157 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91703060 |
| 58 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89653753 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88421869 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87923019 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84938845 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84605424 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83930167 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83812437 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79944069 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79912309 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79890393 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79545556 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.78624324 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76084646 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.75852063 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75683305 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75564587 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74535459 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74163569 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71141382 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.70116910 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69182573 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.68926053 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65986557 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.65891196 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65709636 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65364811 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65167779 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.64205420 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64171043 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.64017464 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63516855 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61927071 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60764983 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60404572 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60235730 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58572690 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57576780 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56189513 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54514665 |
| 97 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54268329 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53838589 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51703899 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51366985 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50696636 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49460048 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48855725 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48381037 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.48378411 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47941242 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47876352 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.47393357 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45567481 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45016410 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.44514476 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43872250 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40662580 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39754731 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39729295 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39588181 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38996580 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38790167 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38745150 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37390303 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35377154 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34545653 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33963150 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33229205 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33030120 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30975107 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27345030 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26144089 |
| 129 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25715671 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23533256 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23138975 |

